July 20, 2018
A New Jersey federal judge on Friday denied most of a biopharmaceutical company's bid to access more than 170 emails by a cancer researcher it claims stole proprietary materials relating to an antibody, but agreed to unshield one message between the researcher and an executive of another biopharmaceutical firm.